The effects of ibuprofen and acetaminophen on orthodontic pain control and interleukin-1β levels in gingival crevicular fluid

2021 ◽  
Vol 18 (2) ◽  
pp. 01-04
Author(s):  
Ganesh Prasad B R ◽  
Keyword(s):  
Pain Control ◽  
Gingival Crevicular Fluid ◽  
Interleukin 1Β ◽  
Orthodontic Pain ◽  
Crevicular Fluid

Interleukin-1β Concentration of Gingival Crevicular Fluid

1994 ◽  
Vol 65 (5) ◽  
pp. 423-428 ◽  
Author(s):  
Dagmar S. Preiss ◽  
Joerg Meyle
Keyword(s):  
Gingival Crevicular Fluid ◽  
Interleukin 1Β ◽  
Crevicular Fluid

Increased Interleukin-1β Concentration in Gingival Crevicular Fluid as a Characteristic of Periodontitis

1999 ◽  
Vol 70 (12) ◽  
pp. 1457-1463 ◽  
Author(s):  
C.M.S. Figueredo ◽  
M.S.M. Ribeiro ◽  
R.G. Fischer ◽  
A. Gustafsson
Keyword(s):  
Gingival Crevicular Fluid ◽  
Interleukin 1Β ◽  
Crevicular Fluid

scholarly journals Oral hygiene in children with epilepsy: Effect of interleukin-1β and VEGF levels in gingival crevicular fluid

2017 ◽  
Vol 54 (1) ◽  
pp. 67-71 ◽  
Author(s):  
Gülsüm Duruk ◽  
Hulya Aksoy ◽  
Taskın Gurbuz ◽  
Esra Laloglu ◽  
Huseyin Tan
Keyword(s):  
Oral Hygiene ◽  
Gingival Crevicular Fluid ◽  
Interleukin 1Β ◽  
Crevicular Fluid

scholarly journals Interleukin 1β Levels around Microscrew Implants during Orthodontic Tooth Movement

2007 ◽  
Vol 77 (6) ◽  
pp. 1073-1078 ◽  
Author(s):  
Emel Sarı ◽  
Cihan Uçar
Keyword(s):  
Treatment Group ◽  
Alveolar Bone ◽  
Tooth Movement ◽  
Gingival Crevicular Fluid ◽  
Orthodontic Tooth Movement ◽  
Experimental Period ◽  
Interleukin 1Β ◽  
Implant Placement ◽  
The Mean ◽  
Crevicular Fluid

Abstract Objective: To determine whether interleukin 1β (IL-1β) levels are elevated around microscrew implants that are used as anchorage for tooth movement. Materials and Methods: Ten young adults, aged 16.3 ± 2.5 years and with all four premolars extracted , comprised the study group. Twenty maxillary microscrew implants were placed bilaterally in the alveolar bone between the maxillary second premolars and first molars as anchorage units for distal movement of the maxillary canines. The maxillary canines served as the treatment group, and the microscrew implants were designated as the implant group. The mandibular canines were used as controls. Peri-microscrew implant crevicular fluid (MICF) and gingival crevicular fluid (GCF) were collected at the beginning of tooth movement (2 weeks after implant placement); at 24, 48, and 168 hours later; and on days 14 and 21. An automated enzyme immunoassay was used to measure 1L-1β in the MICF and the GCF. Results: The mean 1L-1β level in the treatment group was significantly elevated at 24 hours (P = .003 < .05) and 48 hours (P = .003 < .05), whereas the levels in the control and implant groups did not change significantly during the experimental period. Also, the mean 1L-1β level of the treatment group was significantly higher that in both the control and implant groups at 24 and 48 hours. Conclusions: The microscrew implants did not demonstrate increased 1L-1β levels during tooth movement. This supports the concept that microscrew implants might be useful as absolute anchorage devices.

Sign in / Sign up

Export Citation Format

Share Document